Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. - Wikidata - wikimedia - TriplyDB

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

http://www.wikidata.org/entity/Q38812544

about

Elimination of HIV-1-infected cells by broadly neutralizing antibodies The Yin and Yang of ADCC-Mediating Antibodies.Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Prospecting for an HIV vaccine.Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein.Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies.Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.Beyond binding: antibody effector functions in infectious diseases.Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration

P2860

Q27329126-F78E0C87-1268-40F4-BBF6-D1BD3075A36A Q36538736-ABDABE44-4B5F-4523-B838-B8CD995B07E3 Q37363561-EDB75D58-3256-4248-BB2F-56B7BA208B19 Q39189458-304771C3-172C-4622-8D2F-1E14D2958799 Q40051921-8D88D03A-026C-44A0-A990-AAC5DC213F1B Q40088787-3BC9675C-E072-49C2-B157-77EBA85010B1 Q40187580-1E6FEC56-C875-4AC6-BEA6-2A1FEFB9923B Q40279352-364D1DB9-9F09-404C-8BDB-70075ACB5BBB Q40366464-C7BDB7D2-F407-405F-B54F-1E5348FA5BCA Q40448856-B7B31537-E2B8-4C5E-A94D-C6643DBDC4CB Q41924059-CAA7D1AA-C1C0-4E53-B7DA-812B122621AD Q47550536-0EBC50C6-0F89-4E3F-A1C3-0797FAE16F39 Q47564080-C7FEA380-7475-463B-AC90-B857474CFEF4 Q47602559-7B1971AC-6677-4043-A4A6-79B5172FC8C2 Q56969729-722776BC-9333-442A-BA11-C1DDAFEEADEC

P2860

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

http://www.wikidata.org/entity/Q38812544

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

@en

type

label

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

@en

prefLabel

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

@en

P1433

Q38812544-E8713050-77BF-4E18-AB16-07341E70B71A

P1476

Q38812544-57DE1A6E-90B8-41BE-8203-9889550841C4

P2093

Q38812544-2C50DAF1-3641-423E-B6E8-1287CCD50F5E

Q38812544-45738BE8-57D0-449D-978E-E622A34FE03D

Q38812544-4BE27508-324D-4709-A55D-20EDE16526E6

Q38812544-594B1221-C4F3-42AA-97C8-D22448DA4A1B

Q38812544-63E64E6C-D54C-4633-AA48-33D81564CDAB

Q38812544-7D659418-E280-4D7B-86CC-7160CD977E9A

Q38812544-A576CA3A-3397-4641-8F78-BAD09248D9CD

Q38812544-BEB869A4-29AA-4BCC-947E-3D7031E63EDA

Q38812544-E655FD14-5C07-49EB-90A1-86C8D9268066

P2860

Q38812544-034856BF-D6A8-4D6B-9485-991A8BD68F02

Q38812544-037CDA7D-0427-4235-A006-8575FAC7D6CE

Q38812544-06129C49-FD6C-40F1-A8DE-7D8961090A0B

Q38812544-0BFCC8B8-D249-4760-9CBB-3876D94C8FDD

Q38812544-0BFDCA8C-3D92-4F43-ABD2-1BF71E28A5A7

Q38812544-0D78FAE5-8C0E-4066-A179-1ACC46DC58A0

Q38812544-0ECCF892-CB86-446E-88C3-6AD89F2F9989

Q38812544-11D529E1-25A2-4369-8B7D-B85204B3DED7

Q38812544-19DBD51D-CCA4-4D9A-9471-C80532846D29

Q38812544-1AE9CDB1-1B03-4B56-9CB6-C9B52AE304C5

P304

Q38812544-5F9E9D47-9E0C-4CCE-AE3D-E7266B5F6926

P31

Q38812544-11CC243A-E2BF-4694-894B-CB0DD407F522

P356

Q38812544-3179DB3B-BA18-4C33-B559-79F3844E2916

P407

Q38812544-70675D4F-55FC-4E1C-859D-5F88B9AC6B68

P433

Q38812544-082F0C63-5DEB-4A45-A93F-EAD5904C95E2

P478

Q38812544-726732FC-217E-4333-AE3C-517D6B5E0BBB

P50

Q38812544-38A7174B-F774-4A3A-B01F-32B1E0E8AF9A

Q38812544-E5EE25E0-8468-4FF2-9E1C-243784A198C3

Q38812544-F5A46328-B1B2-46FA-9AC8-3BB8BB7A2FAE

P577

Q38812544-49820A42-9692-4069-B1AD-3FFFF7A70F45

P698

Q38812544-89C19A41-C819-4A9B-A0EB-0F3CEC371B43

P921

Q38812544-F34A63BC-A363-4FFA-B62E-D2B3CBDE9E2D

P932

Q38812544-0D3269C5-3A58-408D-923B-9DE927EE40B2

P356

P1433

Journal of Virology

P1476

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

@en

P2093

Amos B Smith

http://www.w3.org/2001/XMLSchema#string

Bruno N Melillo

http://www.w3.org/2001/XMLSchema#string

Daniel E Kaufmann

http://www.w3.org/2001/XMLSchema#string

Joel R Courter

http://www.w3.org/2001/XMLSchema#string

Jonathan Richard

http://www.w3.org/2001/XMLSchema#string

Jongwoo Park

http://www.w3.org/2001/XMLSchema#string

Joseph G Sodroski

http://www.w3.org/2001/XMLSchema#string

Marit Lichtfuss

http://www.w3.org/2001/XMLSchema#string

Matthew S Parsons

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-Based Design and Synthesis of an HIV-1 Entry Inhibitor Exploiting X-Ray and Thermodynamic Characterization

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.

Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity.

P304

2021-2030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02717-15

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J. Kent

P577

2015-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26656700

http://www.w3.org/2001/XMLSchema#string

P921

P932

4733999

http://www.w3.org/2001/XMLSchema#string